Emergence of Trichophyton indotineae in Switzerland (2014-2025): Clinical analysis and antifungal susceptibility [0.03%]
瑞士（2014-2025）曲霉病原菌新物种曲霉素小孢子菌的临床分析和抗真菌敏感性研究
Annabel H Lechner,Dennis D Arnold,Philipp P Bosshard
Annabel H Lechner
Background and objectives: Trichophyton indotineae is an emerging dermatophyte associated with chronic, recalcitrant dermatophytosis and terbinafine resistance due to squalene epoxidase (SQLE) mutations. We analyzed clini...
Response to interleukin-4 receptor alpha inhibitors in a dystrophic epidermolysis bullosa patient with esophageal stenosis [0.03%]
IL-4Rα抑制剂治疗营养不良性大疱性表皮松解症合并食管狭窄患者的疗效观察
Yan Wang,Jie Zhang,Ya-Gang Zuo
Yan Wang
Comment on "Integrating social media into modern dermatology - a cross-sectional study" [0.03%]
关于“将社交媒体融入现代皮肤病学——一项横断面研究”的评论
Maajid Mohi Ud Din Malik,Rajesh Prasad Jayaswal
Maajid Mohi Ud Din Malik
DRESS syndrome triggered by brentuximab vedotin in Sézary syndrome treated with mogamulizumab: a novel association [0.03%]
博纳吐单抗治疗塞扎里综合征诱发的莫戈珠单抗的新型 Dress 综合征病例报告
Carlos Calvo-Asín,Pablo Ortiz-Romero,Jose Puig-Buendia et al.
Carlos Calvo-Asín et al.
Maria Kinberger,Vera Seidel-Eider,Rose K C Moritz et al.
Maria Kinberger et al.
Mirjana Ziemer,Michael Erdmann,Abbas Agaimy et al.
Mirjana Ziemer et al.
The current classification of sweat gland carcinomas is based on histomorphological characteristics and distinguishes between more than 20 entities. Most patients are older, but some subtypes also affect middle-aged and younger patients. Th...
Robustness of a neural network approved for skin cancer diagnosis against variations in sequential images [0.03%]
针对皮肤癌诊断获批的神经网络对序列图像变化的鲁棒性分析
Alicia Zimmermann,Julia K Winkler,Katharina Kommoss et al.
Alicia Zimmermann et al.
Background: Convolutional neural networks (CNN) for skin cancer classification have shown results comparable to dermatologists but are vulnerable to minor image transformations. We investigated the robustness of a MDR cla...
Alessandro Pileri,Tullio Brunetti,Serena Rupoli et al.
Alessandro Pileri et al.
Background: Brentuximab vedotin (BV) is a targeted therapy for CD30-expressing lymphomas, including Hodgkin lymphoma (HL) and cutaneous T-cell lymphoma (CTCL). While peripheral neuropathy is the most common adverse event,...
Repositioning Non-Ablative Fractional Lasers - Molecular and Histological Insights from a scoping review [0.03%]
基于范围性审查的非剥脱点阵激光换位治疗的相关分子和组织学见解
Guy Erlich,Uwe Paasch,Kevin Jacobsen et al.
Guy Erlich et al.
Near-infrared non-ablative fractional lasers (NAFL) are established for skin rejuvenation and scar treatment and have attracted interest for their expanding therapeutic potential. This scoping review aims to revisit and reposition NAFL with...
Infusion-site reactions to foslevodopa/foscarbidopa in Parkinson's disease [0.03%]
左旋多巴/卡比多巴注射反应在帕金森病中的研究
Veronika Urban,Laura Schreieder,Konstantin Drexler et al.
Veronika Urban et al.